disulfiram has been researched along with Pancreatitis in 4 studies
Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Disulfiram (DSF) is an FDA-proved drug with potential therapeutic effects on inflammatory diseases." | 5.91 | Disulfiram reduces the severity of mouse acute pancreatitis by inhibiting RIPK1-dependent acinar cell necrosis. ( Dai, C; Huang, KL; Huang, QY; Lin, ZH; Liu, YY; Shen, Y; Yu, XY; Yuan, L; Zhang, QY; Zhang, R, 2023) |
| "Severe acute pancreatitis (SAP) is characterized by pancreatic and systemic inflammation and persistent organ failure." | 5.91 | Disulfiram relieves severe acute pancreatitis by inhibiting GSDMD-dependent NETs formation. ( Ding, Z; Han, CQ; Ling, X; Nie, C; Sheng, LP, 2023) |
| "Disulfiram (DSF) is an FDA-proved drug with potential therapeutic effects on inflammatory diseases." | 1.91 | Disulfiram reduces the severity of mouse acute pancreatitis by inhibiting RIPK1-dependent acinar cell necrosis. ( Dai, C; Huang, KL; Huang, QY; Lin, ZH; Liu, YY; Shen, Y; Yu, XY; Yuan, L; Zhang, QY; Zhang, R, 2023) |
| "Severe acute pancreatitis (SAP) is characterized by pancreatic and systemic inflammation and persistent organ failure." | 1.91 | Disulfiram relieves severe acute pancreatitis by inhibiting GSDMD-dependent NETs formation. ( Ding, Z; Han, CQ; Ling, X; Nie, C; Sheng, LP, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, QY | 1 |
| Zhang, R | 1 |
| Zhang, QY | 1 |
| Dai, C | 1 |
| Yu, XY | 1 |
| Yuan, L | 1 |
| Liu, YY | 1 |
| Shen, Y | 1 |
| Huang, KL | 1 |
| Lin, ZH | 1 |
| Ling, X | 1 |
| Nie, C | 1 |
| Sheng, LP | 1 |
| Han, CQ | 1 |
| Ding, Z | 1 |
| Kast, RE | 1 |
| Honda, S | 1 |
| Fujioka, T | 1 |
| Shiota, K | 1 |
| Fujiyama, K | 1 |
| Kubota, T | 1 |
| Murakami, K | 1 |
| Nasu, M | 1 |
1 review available for disulfiram and Pancreatitis
| Article | Year |
|---|---|
Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery.
Topics: Acute Disease; Animals; Antihypertensive Agents; Captopril; Caspase Inhibitors; Disulfiram; Drug Syn | 2008 |
3 other studies available for disulfiram and Pancreatitis
| Article | Year |
|---|---|
Disulfiram reduces the severity of mouse acute pancreatitis by inhibiting RIPK1-dependent acinar cell necrosis.
Topics: Acinar Cells; Acute Disease; Animals; Ceruletide; Disulfiram; Mice; Molecular Docking Simulation; Ne | 2023 |
Disulfiram relieves severe acute pancreatitis by inhibiting GSDMD-dependent NETs formation.
Topics: Acute Disease; Animals; Disulfiram; Extracellular Traps; Inflammation; Mice; Pancreatitis | 2023 |
Effects of ethanol on the pancreas of disulfiram-treated rats.
Topics: Acetaldehyde; Acute Disease; Administration, Oral; Amylases; Animals; Disease Models, Animal; Disulf | 1995 |